$0.70
0.23% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$0.70
-0.03 3.50% 1M
-0.48 40.60% 6M
-1.03 59.59% YTD
-1.00 58.88% 1Y
-12.62 94.78% 3Y
-5.61 88.97% 5Y
-45.71 98.50% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.00 0.23%
ISIN
US23725P1003
Symbol
DRIO
Sector

Key metrics

Market capitalization $26.54m
Enterprise Value $40.62m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.76
P/S ratio (TTM) P/S ratio 1.15
P/B ratio (TTM) P/B ratio 0.37
Revenue growth (TTM) Revenue growth -2.09%
Revenue (TTM) Revenue $23.05m
EBIT (operating result TTM) EBIT $-59.45m
Free Cash Flow (TTM) Free Cash Flow $-39.37m
Cash position $16.41m
EPS (TTM) EPS $-0.97
P/E forward negative
P/S forward 0.99
EV/Sales forward 1.51
Short interest 6.54%
Show more

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a DarioHealth Corp. forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a DarioHealth Corp. forecast:

Buy
100%

Financial data from DarioHealth Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
23 23
2% 2%
100%
- Direct Costs 14 14
7% 7%
60%
9.20 9.20
7% 7%
40%
- Selling and Administrative Expenses 39 39
17% 17%
168%
- Research and Development Expense 23 23
11% 11%
100%
-53 -53
16% 16%
-229%
- Depreciation and Amortization 6.77 6.77
32% 32%
29%
EBIT (Operating Income) EBIT -59 -59
18% 18%
-258%
Net Profit -32 -32
43% 43%
-140%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
PRNewsWire
about one month ago
Company expects to reach an estimated total of 25 new client signings in 2024, representing an approximate 35% growth in client base compared to 2023 NEW YORK , Nov. 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today the signing of four contracts with self-insured employers that are expected to go l...
Neutral
Seeking Alpha
about 2 months ago
DarioHealth Corp. (NASDAQ:DRIO ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Third Quarter 2024 Results Call. [Operator Instructions] This call is being recorded ...
Neutral
PRNewsWire
about 2 months ago
Demonstrated strong improvements in financial performance and business momentum. Q3 revenue of $7.42 million increased 18.7% over Q2 2024 and 111% compared to Q3 2023, driven by expansion of B2B2C revenues.
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Erez Raphael
Employees 276
Founded 2011
Website www.dariohealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today